These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 20506493

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
    Arlet JB, Dimitri D, Pagnoux C, Boyer O, Maisonobe T, Authier FJ, Bloch-Queyrat C, Goulvestre C, Heshmati F, Atassi M, Guillevin L, Herson S, Benveniste O, Mouthon L.
    Neuromuscul Disord; 2006 May; 16(5):334-6. PubMed ID: 16616848
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
    Picard C, Vincent T, Lega JC, Hue S, Fortenfant F, Lakomy D, Humbel RL, Goetz J, Molinari N, Bardin N, Bertin D, Johanet C, Chretien P, Dubucquoi S, Streichenberger N, Desplat-Jégo S, Bossuyt X, Sibilia J, Abreu I, Chevailler A, Fabien N.
    Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
    [Abstract] [Full Text] [Related]

  • 28. [Necrotizing myopathy associated with anti-SRP auto-antibodies: transient efficacy of a therapeutic strategy associating plasma exchanges and rituximab].
    Savey L, Bussone G, Lannuzel A, Goulvestre C, Guillevin L, Mouthon L.
    Presse Med; 2012 Oct; 41(10):1035-7. PubMed ID: 22341948
    [No Abstract] [Full Text] [Related]

  • 29. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
    Kuru S, Suzuki S, Ogata K, Kobayashi M, Ishida C, Watanabe C, Matsumura T.
    Rinsho Shinkeigaku; 2017 Oct 27; 57(10):562-566. PubMed ID: 28954975
    [Abstract] [Full Text] [Related]

  • 30. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle.
    Zheng Y, Liu L, Wang L, Xiao J, Wang Z, Lv H, Zhang W, Yuan Y.
    Rheumatology (Oxford); 2015 Jun 27; 54(6):1017-24. PubMed ID: 25417246
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
    Kawabata T, Komaki H, Saito T, Saito Y, Nakagawa E, Sugai K, Sasaki M, Hayashi YK, Nishino I, Momomura M, Kizawa T, Imagawa T, Yokota S.
    Brain Dev; 2012 Nov 27; 34(10):877-80. PubMed ID: 22436377
    [Abstract] [Full Text] [Related]

  • 33. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
    Ashton C, Junckerstorff R, Bundell C, Hollingsworth P, Needham M.
    Neuromuscul Disord; 2016 Nov 27; 26(11):734-740. PubMed ID: 27665513
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.